A Clinical Observation of 1565nm Non-ablative Fractional Laser in the Treatment of Androgenic Alopecia
Androgenic Alopecia
About this trial
This is an interventional treatment trial for Androgenic Alopecia focused on measuring 1565nm Non-ablative Fractional Laser, Androgenic Alopecia, Treatment
Eligibility Criteria
Inclusion Criteria: Age: 18-40 years old, regardless of gender; Clinical diagnosis of androgenic alopecia The diagnosis was based on the diagnostic criteria for androgenic alopecia in Clinical Dermatology, edited by Zhao Bian; The patient agrees to participate in this trial and signs an informed consent form; The scalp is free of bleeding, ulceration, infection, and other conditions that affect the visual field of laser surgery. Exclusion Criteria: Drugs that affect hair growth, including finasteride tablets, glucocorticoids, and vasoactive drugs, have been used within 6 months before treatment; Those who undergo local scalp treatment within 3 months, including topical drugs, medical cosmetic treatment, etc; Combined with severe damage to important organs such as heart, liver, kidney, and brain; Symptomatic alopecia caused by other diseases, such as lupus erythematosus alopecia and folliculitis alopecia; Scar constitution; Patients with skin malignant tumors or precancerous lesions; Pregnant or nursing; Recent skin infections (such as viruses and bacteria); Those who cannot persist in treatment and follow-up.
Sites / Locations
- Dermatology Derpartment of Xijing HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Active Comparator
1565nm Non-ablative Fractional Laser
Minoxidil
1565nm Non-ablative Fractional Laser combined with Minoxidil for external use
1565nm Non-ablative Fractional Laser
Minoxidil for external use
1565nm Non-ablative Fractional Laser combined with Minoxidil for external use